✦ LIBER ✦

14 SUBGROUPS OF PATIENTS TREATED WITH AN AROMATASE INHIBITOR (ANASTROZOLE) DELIVERED SUBCUTANEOUSLY IN COMBINATION WITH TESTOSTERONE

✍ Scribed by Glaser, R.; Dimitrakakis, C.

Book ID: 123336720
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 64 KB
Volume: 71
Category: Article
ISSN: 0378-5122
DOI: 10.1016/S0378-5122(12)70125-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

0-5. Static disease (no change) is an im

0-5. Static disease (no change) is an important remission criteria in patients treated with the aromatase inhibitor anastrozole

✍ J.F.R. Robertson; D. Lee 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 132 KB

667 - Static disease (sd) of long durati

667 - Static disease (sd) of long duration (≥24 weeks) is an important remission criterion in breast cancer patients treated with the aromatase inhibitor anastrozole (AN)

✍ J.F.R. Robertson; D. Lee 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 256 KB

MP48-05 COMBINATION THERAPY WITH AN AROM

MP48-05 COMBINATION THERAPY WITH AN AROMATASE INHIBITOR IS NEEDED IN ONE OUT OF SIX HYPOGONADAL MEN TREATED WITH CLOMIPHENE CITRATE

✍ Nicholson, Tristan; Johnson, Brett; Brunk, Andrew; Downs, Tracy; Ricke, William; 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 72 KB

Anastrozole, an aromatase inhibitor, and

Anastrozole, an aromatase inhibitor, and medroxyprogesterone acetate therapy in premenopausal obese women with endometrial cancer: a report of two cases successfully treated without hysterectomy

✍ Alexander F. Burnett; Afshin Bahador; Charles Amezcua 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Appearance of an inhibitor to factor VII

Appearance of an inhibitor to factor VIII in a hemophilia A patient with HIV infection treated with combination anti-retroviral therapy

✍ Bleak, Shirley; Rodgers, George M. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 2 views

A phase II trial of capecitabine in comb

A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103)

✍ Tianhong Li, Mengye Guo, William J. Gradishar, Joseph A. Sparano, Edith A. Perez 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 301 KB